CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 673, doi. 10.1111/bcp.12227
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 2014 AND VI 77 AND IP 4
Results: 15
1
2
Use of magnetic resonance imaging in pharmacogenomics.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 684, doi. 10.1111/bcp.12197
- By:
- Publication type:
- Article
3
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. i, doi. 10.1111/bcp.12372
- Publication type:
- Article
4
Opportunities and limitations: the value of pharmacogenetics in clinical practice.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 583, doi. 10.1111/bcp.12354
- By:
- Publication type:
- Article
5
Micro RNAs and their relevance to ABC transporters.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 587, doi. 10.1111/bcp.12251
- By:
- Publication type:
- Article
6
Implementation of TPMT testing.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 704, doi. 10.1111/bcp.12226
- By:
- Publication type:
- Article
7
Understanding genetic variation - the value of systems biology.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 597, doi. 10.1111/bcp.12266
- By:
- Publication type:
- Article
8
The genetics of pro-arrhythmic adverse drug reactions.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 618, doi. 10.1111/bcp.12208
- By:
- Publication type:
- Article
9
Clinical implementation of genetic testing in medicine: a US regulatory science perspective.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 606, doi. 10.1111/bcp.12299
- By:
- Publication type:
- Article
10
Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 695, doi. 10.1111/bcp.12229
- By:
- Publication type:
- Article
11
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 654, doi. 10.1111/bcp.12312
- By:
- Publication type:
- Article
12
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 626, doi. 10.1111/bcp.12220
- By:
- Publication type:
- Article
13
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 715, doi. 10.1111/bcp.12253
- By:
- Publication type:
- Article
14
Genetics of platelet inhibitor treatment.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 642, doi. 10.1111/bcp.12230
- By:
- Publication type:
- Article
15
European Medicines Agency initiatives and perspectives on pharmacogenomics.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 612, doi. 10.1111/bcp.12319
- By:
- Publication type:
- Article